Clinical Trial
Piperacetazine (Quide): a controlled evaluation of the elixir in chronic schizophrenic patients
- PMID: 4987346
Item in Clipboard
Clinical Trial
Piperacetazine (Quide): a controlled evaluation of the elixir in chronic schizophrenic patients
Curr Ther Res Clin Exp.
1970 Jun.
No abstract available
Similar articles
-
Evaluation of piperacetazine (Quide) injection in acute schizophrenics.Curr Ther Res Clin Exp. 1972 Jul;14(7):376-80. Curr Ther Res Clin Exp. 1972. PMID: 4625517 Clinical Trial. No abstract available.
-
Piperacetazine in ambulatory chronic schizophrenic patients.Curr Ther Res Clin Exp. 1974 Feb;16(2):124-9. Curr Ther Res Clin Exp. 1974. PMID: 4156665 Clinical Trial. No abstract available.
-
Quide vs. Mellaril in chronic schizophrenic patients.Curr Ther Res Clin Exp. 1972 Jan;14(1):10-6. Curr Ther Res Clin Exp. 1972. PMID: 4621558 Clinical Trial. No abstract available.
-
An uncontrolled clinical study with piperacetazine in the maintenance treatment of chronic schizophrenic patients.Psychopharmacol Bull. 1977 Jul;13(3):10-1. Psychopharmacol Bull. 1977. PMID: 18753 Clinical Trial. No abstract available.
-
Piperacetazine in chronic mental patients: clinical observations and new urine color test.Curr Ther Res Clin Exp. 1972 Nov;14(11):689-95. Curr Ther Res Clin Exp. 1972. PMID: 4629106 No abstract available.
Cited by
-
Chlorpromazine versus piperacetazine for schizophrenia.Cochrane Database Syst Rev. 2018 Oct 31;10(10):CD011709. doi: 10.1002/14651858.CD011709.pub2. Cochrane Database Syst Rev. 2018. PMID: 30378678 Free PMC article. Review.